NM_001754.5:c.737C>A
Variant summary
Our verdict is Uncertain significance. Variant got -1 ACMG points: 0P and 1B. BP4
This summary comes from the ClinGen Evidence Repository: NM_001754.5(RUNX1):c.737C>A (p.Thr246Lys) is a missense variant which has not been featured in functional or case studies. Computational and population data have been used to evaluate this variant. It is detected in the gnomAD population database (1/1179366 alleles in the European (Non-Finnish) v4 cohort). This variant has a SpliceAI score of 0.01 and a PhyloP score of 7.8, supporting the application of BP4. In summary, this variant meets criteria to be classified as a variant of uncertain significance (VUS). ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BP4. LINK:https://erepo.genome.network/evrepo/ui/classification/CA410206793/MONDO:0011071/008
Frequency
Consequence
NM_001754.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460918Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 726578
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The p.T246K variant (also known as c.737C>A), located in coding exon 6 of the RUNX1 gene, results from a C to A substitution at nucleotide position 737. The threonine at codon 246 is replaced by lysine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. -
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome Uncertain:1
NM_001754.5(RUNX1):c.737C>A (p.Thr246Lys) is a missense variant which has not been featured in functional or case studies. Computational and population data have been used to evaluate this variant. It is detected in the gnomAD population database (1/1179366 alleles in the European (Non-Finnish) v4 cohort). This variant has a SpliceAI score of 0.01 and a PhyloP score of 7.8, supporting the application of BP4. In summary, this variant meets criteria to be classified as a variant of uncertain significance (VUS). ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BP4. -
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 Uncertain:1
This sequence change replaces threonine, which is neutral and polar, with lysine, which is basic and polar, at codon 246 of the RUNX1 protein (p.Thr246Lys). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RUNX1 protein function. ClinVar contains an entry for this variant (Variation ID: 1016211). This variant has not been reported in the literature in individuals affected with RUNX1-related conditions. This variant is not present in population databases (gnomAD no frequency). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at